GATA transcription factors: Basic principles and related human disorders

Tohoku Journal of Experimental Medicine

Volumn 242, Issue 2, 2017, Pages 83-91

  Fujiwara, Tohru ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

GATA 1; GATA 2; Hematological disease; Hematopoiesis; Transcription factor

Indexed keywords

TRANSCRIPTION FACTOR GATA; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR GATA 3;

APLASTIC ANEMIA; BLOOD CELL; CELL MATURATION; DISEASE ASSOCIATION; EOSINOPHIL; ERYTHROCYTE; GENE EXPRESSION REGULATION; GENE MUTATION; HEMATOLOGIC DISEASE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; LYMPHATIC LEUKEMIA; MAST CELL; MEGAKARYOCYTE; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; ANIMAL; CHEMISTRY; DISEASES; GENETIC ASSOCIATION STUDY; GENETICS; METABOLISM; MUTATION;

ANIMALS; DISEASE; GATA TRANSCRIPTION FACTORS; GENETIC ASSOCIATION STUDIES; HUMANS; MUTATION;

EID: 85020408461     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.242.83     Document Type: Review

References (101)

1. Amann, J.M., Nip, J., Strom, D.K., Lutterbach, B., Harada, H., Lenny, N., Downing, J.R., Meyers, S. & Hiebert, S.W. (2001) ETO, a target of t (8; 21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. Mol. Cell. Biol., 21, 6470-6483.
2. Antonchuk, J., Sauvageau, G. & Humphries, R.K. (2002) HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell, 109, 39-45.
3. Bacigalupo, A., Bruno, B., Saracco, P., Di Bona, E., Locasciulli, A., Locatelli, F., Gabbas, A., Dufour, C., Arcese, W., Testi, G., Broccia, G., Carotenuto, M., Coser, P., Barbui, T., Leoni, P. & Ferster, A. (2000) Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. Blood, 95, 1931-1934.
4. Balduini, C.L., Pecci, A., Loffredo, G., Izzo, P., Noris, P., Grosso, M., Bergamaschi, G., Rosti, V., Magrini, U., Ceresa, I.F., Conti, V., Poggi, V. & Savoia, A. (2004) Effects of the R216Q mutation of GATA-1 on erythropoiesis and megakaryocytopoiesis. Thromb. Haemost., 91, 129-140.
5. Bödör, C., Renneville, A., Smith, M., Charazac, A., Iqbal, S., Etancelin, P., Cavenagh, J., Barnett, M.J., Kramarzová, K., Krishnan, B., Matolcsy, A., Preudhomme, C., Fitzgibbon, J. & Owen, C. (2012) Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival. Haematologica, 97, 890-894.
6. Bresnick, E.H., Lee, H.Y., Fujiwara, T., Johnson, K.D. & Keles, S. (2010) GATA switches as developmental drivers. J. Biol. Chem., 285, 31087-31093.
7. Campagna, D.R., de Bie, C.I., Schmitz-Abe, K., Sweeney, M., Sendamarai, A.K., Schmidt, P.J., Heeney, M.M., Yntema, H.G., Kannengiesser, C., Grandchamp, B., Niemeyer, C.M., Knoers, N.V., Swart, S., Marron, G., van Wijk, R., et al. (2014) X-linked sideroblastic anemia due to ALAS2 intron 1 enhancer element GATA-binding site mutations. Am. J. Hematol., 89, 315-319.
8. Churpek, J.E., Pyrtel, K., Kanchi, K.L., Shao, J., Koboldt, D., Miller, C.A., Shen, D., Fulton, R., O’Laughlin, M., Fronick, C. & Pusic, I. (2015) Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia. Blood, 126, 2484-2490.
9. Collin, M., Dickinson, R. & Bigley, V. (2015) Haematopoietic and immune defects associated with GATA2 mutation. Br. J. Haematol., 169, 173-187.
10. Crispino, J.D. & Horwitz, M.S. (2017) GATA factor mutations in hematologic disease. Blood, 129, 2103-2110.
11. Di Pierro, E., Russo, R., Karakas, Z., Brancaleoni, V., Gambale, A., Kurt, I., Winter, S.S., Granata, F., Czuchlewski, D.R., Langella, C., Lolascon, A. & Cappellini, M.D. (2015) Congenital erythropoietic porphyria linked to GATA1-R216W mutation: challenges for diagnosis. Eur. J. Haematol., 94, 491-497.
12. Dickinson, R.E., Griffin, H., Bigley, V., Reynard, L.N., Hussain, R., Haniffa, M., Lakey, J.H., Rahman, T., Wang, X.N., McGovern, N., Pagan, S., Cookson, S., McDonald, D., Chua, I., Wallis, J., et al. (2011) Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency. Blood, 118, 2656-2658.
13. Dumitriu, B., Feng, X., Townsley, D.M., Ueda, Y., Yoshizato, T., Calado, R.T., Yang, Y., Wakabayashi, Y., Kajigaya, S., Ogawa, S., Zhu, J. & Young, N.S. (2015) Telomere attrition and candidate gene mutations preceding monosomy 7 in aplastic anemia. Blood, 125, 706-709.
14. Evans, T., Reitman, M. & Felsenfeld, G. (1988) An erythrocytespecific DNA-binding factor recognizes a regulatory sequence common to all chicken globin genes. Proc. Natl. Acad. Sci. USA, 85, 5976-5980.
15. Ezoe, S., Matsumura, I., Nakata, S., Gale, K., Ishihara, K., Minegishi, N., Machii, T., Kitamura, T., Yamamoto, M., Enver, T. & Kanakura, Y. (2002) GATA-2/estrogen receptor chimera regulates cytokine-dependent growth of hematopoietic cells through accumulation of p21WAF1 and p27Kip1 proteins. Blood, 100, 3512-3520.
16. Frenette, P.S., Pinho, S., Lucas, D. & Scheiermann, C. (2013) Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine. Annu. Rev. Immunol., 31, 285-316.
17. Freson, K., Devriendt, K., Matthijs, G., Van Hoof, A., De Vos, R., Thys, C., Minner, K., Hoylaerts, M.F., Vermylen, J. & Van Geet, C. (2001) Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation. Blood, 98, 85-92.
18. Fujimaki, S., Harigae, H., Sugawara, T., Takasawa, N., Sasaki, T. & Kaku, M. (2001) Decreased expression of transcription factor GATA-2 in haematopoietic stem cells in patients with aplastic anaemia. Br. J. Haematol., 113, 52-57.
19. Fujiwara, T., Alqadi, Y.W., Okitsu, Y., Fukuhara, N., Onishi, Y., Ishizawa, K. & Harigae, H. (2013) Role of transcriptional corepressor ETO2 in erythroid cells. Exp. Hematol., 41, 303-315.
20. Fujiwara, T., Fukuhara, N., Funayama, R., Nariai, N., Kamata, M., Nagashima, T., Kojima, K., Onishi, Y., Sasahara, Y., Ishizawa, K., Nagasaki, M., Nakayama, K. & Harigae, H. (2014) Identification of acquired mutations by whole-genome sequencing in GATA-2 deficiency evolving into myelodysplasia and acute leukemia. Ann. Hematol., 93, 1515-1522.
21. Fujiwara, T. & Harigae, H. (2013) Pathophysiology and genetic mutations in congenital sideroblastic anemia. Pediatr. Int., 55, 675-679.
22. Fujiwara, T., Lee, H.Y., Sanalkumar, R. & Bresnick, E.H. (2010) Building multifunctionality into a complex containing master regulators of hematopoiesis. Proc. Natl. Acad. Sci. USA, 107, 20429-20434.
23. Fujiwara, T., O’Geen, H., Keles, S., Blahnik, K., Linnemann, A.K., Kang, Y.A., Choi, K., Farnham, P.J. & Bresnick, E.H. (2009) Discovering hematopoietic mechanisms through genome-wide analysis of GATA factor chromatin occupancy. Mol. Cell, 36, 667-681.
24. Fujiwara, T., Sasaki, K., Saito, K., Hatta, S., Ichikawa, S., Kobayashi, M., Okitsu, Y., Fukuhara, N., Onishi, Y. & Harigae, H. (2017) Forced FOG1 expression in erythroleukemia cells: Induction of erythroid genes and repression of myelo-lymphoid transcription factor PU. 1. Biochem. Biophys. Res. Commun., 485, 380-387.
25. Fujiwara, T., Yokoyama, H., Okitsu, Y., Kamata, M., Fukuhara, N., Onishi, Y., Fujimaki, S., Takahashi, S., Ishizawa, K., Bresnick, E.H. & Harigae, H. (2012) Gene expression profiling identifies HOXB4 as a direct downstream target of GATA-2 in human CD34+ hematopoietic cells. PLoS One, 7, e40959.
26. Fujiwara, Y., Browne, C.P., Cunniff, K., Goff, S.C. & Orkin, S.H. (1996) Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc. Natl. Acad. Sci. USA, 93, 12355-12358.
27. Fujiwara, Y., Chang, A.N., Williams, A.M. & Orkin, S.H. (2004) Functional overlap of GATA-1 and GATA-2 in primitive hematopoietic development. Blood, 103, 583-585.
28. Gao, J., Chen, Y.H. & Peterson, L.C. (2015) GATA family transcriptional factors: emerging suspects in hematologic disorders. Exp. Hematol. Oncol., 4, 28.
29. Gilles, L., Arslan, A.D., Marinaccio, C., Wen, Q.J., Arya, P., McNulty, M., Yang, Q., Zhao, J.C., Konstantinoff, K., Lasho, T., Pardanani, A., Stein, B., Plo, I., Sundaravel, S., Wickrema, A., et al. (2017) Downregulation of GATA1 drives impaired hematopoiesis in primary myelofibrosis. J. Clin. Invest., 127, 1316-1320.
30. Göttgens, B., Nastos, A., Kinston, S., Piltz, S., Delabesse, E.C., Stanley, M., Sanchez, M.J., Ciau-Uitz, A., Patient, R. & Green, A. R. (2002) Establishing the transcriptional programme for blood: the SCL stem cell enhancer is regulated by a multiprotein complex containing Ets and GATA factors. EMBO J., 21, 3039-3050.
31. Groet, J., McElwaine, S., Spinelli, M., Rinaldi, A., Burtscher, I., Mulligan, C., Mensah, A., Cavani, S., Dagna-Bricarelli, F., Basso, G., Cotter, F.E. & Nizetic, D. (2003) Acquired mutations in GATA1 in neonates with Down’s syndrome with transient myeloid disorder. Lancet, 361, 1617-1620.
32. Gröschel, S., Sanders, M.A., Hoogenboezem, R., de Wit, E., Bouwman, B.A., Erpelinck, C., van der Velden, V.H., Havermans, M., Avellino, R., van Lom, K., Rombouts, E.J., van Duin, M., Döhner, K., Beverloo, H.B., Bradner, J.E., et al. (2014) A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia. Cell, 157, 369-381.
33. Grossman, J., Cuellar-Rodriguez, J., Gea-Banacloche, J., Zerbe, C., Calvo, K., Hughes, T., Hakim, F., Cole, K., Parta, M., Freeman, A., Holland, S.M. & Hickstein, D.D. (2014) Nonmyeloablative allogeneic hematopoietic stem cell transplantation for GATA2 deficiency. Biol. Blood Marrow Transplant., 20, 1940-1948.
34. Hahn, C.N., Chong, C.E., Carmichael, C.L., Wilkins, E.J., Brautigan, P.J., Li, X.C., Babic, M., Lin, M., Carmagnac, A., Lee, Y.K., Kok, C.H., Gagliardi, L., Friend, K.L., Ekert, P.G., Butcher, C.M. et al. (2011) Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat. Genet., 43, 1012-1017.
35. Harigae, H., Xu, G., Sugawara, T., Ishikawa, I., Toki, T. & Ito, E. (2004) The GATA1 mutation in an adult patient with acute megakaryoblastic leukemia not accompanying Down syndrome. Blood, 103, 3242-3243.
36. Hasegawa, A., Kaneko, H., Ishihara, D., Nakamura, M., Watanabe, A., Yamamoto, M., Trainor, C.D. & Shimizu, R. (2016) GATA1 Binding Kinetics on Conformation-Specific Binding Sites Elicit Differential Transcriptional Regulation. Mol. Cell. Biol., 36, 2151-2167.
37. Hitzler, J.K., Cheung, J., Li, Y., Scherer, S.W. & Zipursky, A. (2003) GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome. Blood, 101, 4301-4304.
38. Hollanda, L.M., Lima, C.S., Cunha, A.F., Albuquerque, D.M., Vassallo, J., Ozelo, M.C., Joazeiro, P.P., Saad, S.T. & Costa, F.F. (2006) An inherited mutation leading to production of only the short isoform of GATA-1 is associated with impaired erythropoiesis. Nat. Genet., 38, 807-812.
39. Hopfer, O., Nolte, F., Mossner, M., Komor, M., Kmetsch, A., Benslasfer, O., Reissmann, M., Nowak, D., Hoelzer, D., Thiel, E. & Hofmann, W.K. (2012) Epigenetic dysregulation of GATA1 is involved in myelodysplastic syndromes dyserythropoiesis. Eur. J. Haematol., 88, 144-153.
40. Hsu, A.P., Sampaio, E.P., Khan, J., Calvo, K.R., Lemieux, J.E., Patel, S.Y., Frucht, D.M., Vinh, D.C., Auth, R.D., Freeman, A.F., Olivier, K.N., Uzel, G., Zerbe, C.S., Spalding, C., Pittaluga, S., et al. (2011) Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood, 118, 2653-2655.
41. Inoue, A., Fujiwara, T., Okitsu, Y., Katsuoka, Y., Fukuhara, N., Onishi, Y., Ishizawa, K. & Harigae, H. (2013) Elucidation of the role of LMO2 in human erythroid cells. Exp. Hematol., 41, 1062-1076.
42. Johnson, K.D., Hsu, A.P., Ryu, M.J., Wang, J., Gao, X., Boyer, M.E., Liu, Y., Calvo, K.R., Keles, S., Zhang, J., Holland, S.M. & Bresnick, E.H. (2012) Cis-element mutated in GATA2-dependent immunodeficiency governs hematopoiesis and vascular integrity. J. Clin. Invest., 122, 3692-3704.
43. Johnson, K.D., Kim, S.I. & Bresnick, E.H. (2006) Differential sensitivities of transcription factor target genes underlie cell type-specific gene expression profiles. Proc. Natl. Acad. Sci. USA, 103, 15939-15944.
44. Kamata, M., Okitsu, Y., Fujiwara, T., Kanehira, M., Nakajima, S., Takahashi, T., Inoue, A., Fukuhara, N., Onishi, Y., Ishizawa, K., Shimizu, R., Yamamoto, M. & Harigae, H. (2014) GATA2 regulates differentiation of bone marrow-derived mesenchymal stem cells. Haematologica, 99, 1686-1696.
45. Kaneko, K., Furuyama, K., Fujiwara, T., Kobayashi, R., Ishida, H., Harigae, H. & Shibahara, S. (2014) Identification of a novel erythroid-specific enhancer for the ALAS2 gene and its lossof-function mutation which is associated with congenital sideroblastic anemia. Haematologica, 99, 252-261.
46. Katagiri, T., Sato-Otsubo, A., Kashiwase, K., Morishima, S., Sato, Y., Mori, Y., Kato, M., Sanada, M., Morishima, Y., Hosokawa, K., Sasaki, Y., Ohtake, S., Ogawa, S. & Nakao, S. (2011) Japan Marrow Donor Program. Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia. Blood, 118, 6601-6609.
47. Kerenyi, M.A. & Orkin, S.H. (2010) Networking erythropoiesis. J. Exp. Med., 207, 2537-2541.
48. Klar, J., Khalfallah, A., Arzoo, P.S., Gazda, H.T. & Dahl, N. (2014) Recurrent GATA1 mutations in Diamond-Blackfan anaemia. Br. J. Haematol., 166, 949-951.
49. Kumar, M.S., Hancock, D.C., Molina-Arcas, M., Steckel, M., East, P., Diefenbacher, M., Armenteros-Monterroso, E., Lassailly, F., Matthews, N., Nye, E., Stamp, G., Behrens, A. & Downward, J. (2012) The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancer. Cell, 149, 642-655.
50. Lahlil, R., Lécuyer, E., Herblot, S. & Hoang, T. (2004) SCL assembles a multifactorial complex that determines glycophorin A expression. Mol. Cell. Biol., 24, 1439-1452.
51. Lim, K.C., Lakshmanan, G., Crawford, S.E., Gu, Y., Grosveld, F. & Engel, J.D. (2000) Gata3 loss leads to embryonic lethality due to noradrenaline deficiency of the sympathetic nervous system. Nat. Genet., 25, 209-212.
52. Lipton, J.M. & Ellis, S.R. (2009) Diamond-Blackfan anemia: diagnosis, treatment, and molecular pathogenesis. Hematol. Oncol. Clin. North Am., 23, 261-282.
53. Ludwig, L.S., Gazda, H.T., Eng, J.C., Eichhorn, S.W., Thiru, P., Ghazvinian, R., George, T.I., Gotlib, J.R., Beggs, A.H., Sieff, C.A., Lodish, H.F., Lander, E.S. & Sankaran, V.G. (2014) Altered translation of GATA1 in Diamond-Blackfan anemia. Nat. Med., 20, 748-753.
54. Makishima, H., Yoshizato, T., Yoshida, K., Sekeres, M.A., Radivoyevitch, T., Suzuki, H., Przychodzen, B., Nagata, Y., Meggendorfer, M., Sanada, M., Okuno, Y., Hirsch, C., Kuzmanovic, T., Sato, Y., Sato-Otsubo, A., et al. (2017) Dynamics of clonal evolution in myelodysplastic syndromes. Nat. Genet., 49, 204-212.
55. Martin, D.I., Tsai, S.F. & Orkin, S.H. (1989) Increased γ-globin expression in a nondeletion HPFH mediated by an erythroidspecific DNA-binding factor. Nature, 338, 435-438.
56. Massey, G.V., Zipursky, A., Chang, M.N., Doyle, J.J., Nasim, S., Taub, J.W., Ravindranath, Y., Dahl, G. & Weinstein, H.J. (2006) A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children’s Oncology Group (COG) study POG-9481. Blood, 107, 4606-4613.
57. Mehaffey, M.G., Newton, A.L., Gandhi, M.J., Crossley, M. & Drachman, J.G. (2001) X-linked thrombocytopenia caused by a novel mutation of GATA-1. Blood, 98, 2681-2688.
58. Minegishi, N., Ohta, J., Yamagiwa, H., Suzuki, N., Kawauchi, S., Zhou, Y., Takahashi, S., Hayashi, N., Engel, J.D. & Yamamoto, M. (1999) The mouse GATA-2 gene is expressed in the paraaortic splanchnopleura and aorta-gonads and mesonephros region. Blood, 93, 4196-4207.
59. Müller, J., Hart, C.M., Francis, N.J., Vargas, M.L., Sengupta, A., Wild, B., Miller, E.L., O’Connor, M.B., Kingston, R.E. & Simon, J.A. (2002) Histone methyltransferase activity of a Drosophila Polycomb group repressor complex. Cell, 111, 197-208.
60. Nei, Y., Obata-Ninomiya, K., Tsutsui, H., Ishiwata, K., Miyasaka, M., Matsumoto, K., Nakae S., Kanuka, H., Inase, N. & Karasuyama, H. (2013) GATA-1 regulates the generation and function of basophils. Proc. Natl. Acad. Sci. USA, 110, 18620-18625.
61. Nichols, K.E., Crispino, J.D., Poncz, M., White, J.G., Orkin, S.H., Maris, J.M. & Weiss, M.J. (2002) Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1. Nat. Genet., 24, 266-270.
62. Okitsu, Y., Takahashi, S., Minegishi, N., Kameoka, J., Kaku, M., Yamamoto, M., Sasaki, T. & Harigae, H. (2007) Regulation of adipocyte differentiation of bone marrow stromal cells by transcription factor GATA-2. Biochem. Biophys. Res. Commun., 364, 383-387.
63. Onodera, K., Fujiwara, T., Onishi, Y., Itoh-Nakadai, A., Okitsu, Y., Fukuhara, N., Ishizawa, K., Shimizu, R., Yamamoto, M. & Harigae, H. (2016) GATA2 regulates dendritic cell differentiation. Blood, 128, 508-518.
64. Orkin, S.H. (1992) GATA-binding transcription factors in hematopoietic cells. Blood, 80, 575-581.
65. Ostergaard, P., Simpson, M.A., Connell, F.C., Steward, C.G., Brice, G., Woollard, W.J., Dafou, D., Kilo, T., Smithson, S., Lunt, P., Murday, V.A., Hodgson, S., Keenan, R., Pilz, D.T., Martinez-Corral, I., et al. (2011) Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat. Genet., 43, 929-931.
66. Parrella, S., Aspesi, A., Quarello, P., Garelli, E., Pavesi, E., Carando, A., Nardi, M., Ellis, S.R., Ramenghi, U. & Dianzani, I. (2014) Loss of GATA-1 full length as a cause of Diamond-Blackfan anemia phenotype. Pediatr. Blood Cancer, 61, 1319-1321.
67. Persons, D.A., Allay, J.A., Allay, E.R., Ashmun, R.A., Orlic, D., Jane, S.M., Cunningham, J.M. & Nienhuis, A.W. (1999) Enforced expression of the GATA-2 transcription factor blocks normal hematopoiesis. Blood, 93, 488-499.
68. Pevny, L., Simon, M.C., Robertson, E., Klein, W.H., Tsai, S.F., D’Agati, V., Orkin, S.H. & Costantini, F. (1991) Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature, 349, 257.
69. Phillips, J.D., Steensma, D.P., Pulsipher, M.A., Spangrude, G.J. & Kushner, J.P. (2007) Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria. Blood, 109, 2618-2621.
70. Rodrigues, N.P., Janzen, V., Forkert, R., Dombkowski, D.M., Boyd, A.S., Orkin, S.H., Enver, T., Vyas, P. & Scadden, D.T. (2005) Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis. Blood, 106, 477-484.
71. Rodriguez-Bravo, V., Carceles-Cordon, M., Hoshida, Y., Cordon-Cardo, C., Galsky, M.D. & Domingo-Domenech, J. (2017) The role of GATA2 in lethal prostate cancer aggressiveness. Nat. Rev. Urol., 14, 38-48.
72. Saito, Y., Fujiwara, T., Ohashi, K., Okitsu, Y., Fukuhara, N., Onishi, Y., Ishizawa, K. & Harigae, H. (2015) High-Throughput siRNA Screening to Reveal GATA-2 Upstream Transcriptional Mechanisms in Hematopoietic Cells. PLoS One, 10, e0137079.
73. Sankaran, V.G., Ghazvinian, R., Do, R., Thiru, P., Vergilio, J.A., Beggs, A.H., Sieff, C.A., Orkin, S.H., Nathan, D.G., Lander, E.S. & Gazda, H.T. (2012) Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia. J. Clin. Invest., 122, 2439-2443.
74. Shimizu, R., Kobayashi, E., Engel, J.D. & Yamamoto, M. (2009) Induction of hyperproliferative fetal megakaryopoiesis by an N-terminally truncated GATA1 mutant. Genes Cells, 14, 1119-1131.
75. Shivdasani, R.A., Mayer, E.L. & Orkin, S.H. (1995) Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature, 373, 432-434.
76. Soler, E., Andrieu-Soler, C., de Boer, E., Bryne, J.C., Thongjuea, S., Stadhouders, R., Palstra, R.J., Stevens, M., Kockx, C., van Ijcken, W., Hou, J., Steinhoff, C., Rijkers, E., Lenhard, B. & Grosveld, F. (2010) The genome-wide dynamics of the binding of Ldb1 complexes during erythroid differentiation. Genes Dev., 24, 277-289.
77. Solomou, E.E., Rezvani, K., Mielke, S., Malide, D., Keyvanfar, K., Visconte, V., Kajigaya, S., Barrett, A.J. & Young, N.S. (2007) Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia. Blood, 110, 1603-1606.
78. Tong, Q., Dalgin, G., Xu, H., Ting, C.N., Leiden, J.M. & Hotamisligil, G.S. (2000) Function of GATA transcription factors in preadipocyte–adipocyte transition. Science, 290, 134-138.
79. Trainor, C.D., Omichinski, J.G., Vandergon, T.L., Gronenborn, A.M., Clore, G.M. & Felsenfeld, G. (1996) A palindromic regulatory site within vertebrate GATA-1 promoters requires both zinc fingers of the GATA-1 DNA-binding domain for high-affinity interaction. Mol. Cell. Biol., 16, 2238-2247.
80. Tripic, T., Deng, W., Cheng, Y., Zhang, Y., Vakoc, C.R., Gregory, G.D., Hardison, R.C. & Blobel, G.A. (2009) SCL and associated proteins distinguish active from repressive GATA transcription factor complexes. Blood, 113, 2191-2201.
81. Tsai, F.Y., Keller, G., Kuo, F.C., Weiss, M., Chen, J., Rosenblatt, M., Alt, F.W. & Orkin, S.H. (1994) An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature, 371, 221-226.
82. Tsai, F.Y. & Orkin, S.H. (1997) Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood, 89, 3636-3643.
83. Tubman, V.N., Levine, J.E., Campagna, D.R., Monahan-Earley, R., Dvorak, A.M., Neufeld, E.J. & Fleming, M.D. (2007) X-linked gray platelet syndrome due to a GATA1 Arg216Gln mutation. Blood, 109, 3297-3299.
84. Vinh, D.C., Patel, S.Y., Uzel, G., Anderson, V.L., Freeman, A.F., Olivier, K.N., Spalding, C., Hughes, S., Pittaluga, S., Raffeld, M., Sorbara, L.R., Elloumi, H.Z., Kuhns, D.B., Turner, M.L., Cowen, E.W., et al. (2010) Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. Blood, 115, 1519-1529.
85. Vyas, P., Ault, K., Jackson, C.W., Orkin, S.H. & Shivdasani, R.A. (1999) Consequences of GATA-1 deficiency in megakaryocytes and platelets. Blood, 93, 2867-2875.
86. Wadman, I.A., Osada, H., Grütz, G.G., Agulnick, A.D., Westphal, H., Forster, A. & Rabbitts, T.H. (1997) The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNAbinding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO J., 16, 3145-3157.
87. Wall, L., deBoer, E. & Grosveld, F. (1988) The human beta-globin gene 3′enhancer contains multiple binding sites for an erythroid-specific protein. Genes Dev., 2, 1089-1100.
88. Wechsler, J., Greene, M., McDevitt, M.A., Anastasi, J., Karp, J.E., Le Beau, M.M. & Crispino, J.D. (2002) Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat. Genet., 32, 148-152.
89. West, R.R., Hsu, A.P., Holland, S.M., Cuellar-Rodriguez, J. & Hickstein, D.D. (2014) Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation. Haematologica., 99, 276-281.
90. Xu, Y., Takahashi, Y., Wang, Y., Hama, A., Nishio, N., Muramatsu, H., Tanaka, M., Yoshida, N., Villalobos, I.B., Yagasaki, H. & Kojima, S. (2009) Downregulation of GATA-2 and overexpression of adipogenic gene-PPARgamma in mesenchymal stem cells from patients with aplastic anemia. Exp. Hematol., 37, 1393-1399.
91. Yamamoto, M., Ko, L.J., Leonard, M.W., Beug, H., Orkin, S.H. & Engel, J.D. (1990) Activity and tissue-specific expression of the transcription factor NF-E1 multigene family. Genes Dev., 4, 1650-1662.
92. Yamazaki, H., Suzuki, M., Otsuki, A., Shimizu, R., Bresnick, E.H., Engel, J.D. & Yamamoto, M. (2014) A remote GATA2 hematopoietic enhancer drives leukemogenesis in inv (3) (q21; q26) by activating EVI1 expression. Cancer Cell, 25, 415-427.
93. Yoshida, K., Toki, T., Okuno, Y., Kanezaki, R., Shiraishi, Y., Sato-Otsubo, A., Sanada, M., Park, M.J., Terui, K., Suzuki, H., Kon, A., Nagata, Y., Sato, Y., Wang, R., Shiba, N., et al. (2013) The landscape of somatic mutations in Down syndromerelated myeloid disorders. Nat. Genet., 45, 1293-1299 (Erratum in Nat. Genet. 2013, 45, 1516).
94. Young, N.S. (1999) Acquired aplastic anemia. JAMA, 282, 271-278 (Erratum in JAMA 2000, 283, 57).
95. Young, N.S., Bacigalupo, A. & Marsh, J.C. (2010) Aplastic anemia: pathophysiology and treatment. Biol. Blood Marrow Transplant., 16, S119-125.
96. Young, N.S., Scheinberg, P. & Calado, R.T. (2008) Aplastic anemia. Curr. Opin. Hematol., 15, 162-168.
97. Yu, C., Cantor, A.B., Yang, H., Browne, C., Wells, R.A., Fujiwara, Y. & Orkin, S.H. (2002a) Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo. J. Exp. Med., 195, 1387-1395.
98. Yu, C., Niakan, K.K., Matsushita, M., Stamatoyannopoulos, G., Orkin, S.H. & Raskind, W.H. (2002b) X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction. Blood, 100, 2040-2045.
99. Zeng, W., Chen, G., Kajigaya, S., Nunez, O., Charrow, A., Billings, E.M. & Young, N.S. (2004) Gene expression profiling in CD34 cells to identify differences between aplastic anemia patients and healthy volunteers. Blood, 103, 325-332.
100. Zhang, S.J., Ma, L.Y., Huang, Q.H., Li, G., Gu, B.W., Gao, X.D., Shi, J.Y., Wang, Y.Y., Gao L, Cai, X., Ren, R.B., Zhu, J., Chen, Z. & Chen, S.J. (2008) Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia. Proc. Natl. Acad. Sci. USA, 105, 2076-2081.
101. Zon, L.I., Yamaguchi, Y., Yee, K., Albee, E.A., Kimura, A., Bennett, J.C., Orkin, S.H. & Ackerman, S.J. (1993) Expression of mRNA for the GATA-binding proteins in human eosinophils and basophils: potential role in gene transcription. Blood, 81, 3234-3241.